Abstract: A method for removing fouling from a pipeline includes determining the location of fouling in the pipeline. Once determined, the method further includes installing a hot tap in the pipeline. A flex conduit is inserted into the pipeline through the hot tap and a treatment fluid is flowed into the pipeline through the conduit. The treatment fluid is used to remove the fouling from the pipeline. Once the fouling is sufficiently removed, the flexible conduit is removed from the pipeline.

Abstract: The present application pertains to methods of using indole-oxadiazole compounds of Formula I to modulate cannabinoid receptor activity: I In particular diseases, disorders or conditions that benefit from modulating cannabinoid receptor activity, such as non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), schizophrenia, bipolar disorder, psychosis, metabolic syndrome, type-2 diabetes, dyslipidaemia, obesity, eating disorders, cardiovascular diseases and disorders, and other conditions as described herein, may be treated. Also included in the present application are certain novel compounds of Formula Ia and pharmaceutical compositions comprising these compounds.

Abstract: A hybrid coiled tubing system. The hybrid coiled tubing system may include composite coiled tubing, metallic coiled tubing, and a composite coiled tubing connector coupled to and joining the composite coiled tubing and the metallic coiled tubing.

Abstract: A subsea pump and power system having a base unit positioned on the seabed to which is detachably mounted a power module tethered to a surface power source via a power umbilical. The base unit includes process pumps for carrying out subsea pumping operations and is lowered by a heavy lift cable into position on the seabed adjacent a hydrocarbon production facility prior to lowering of the power module on a tether. The power module includes a power unit which may include an electrical motor, or a hydraulic pump or both, one or more of which are driven by the umbilical extending from the surface. The tether supports the weight of the power module as it is lowered to the base unit and includes an electrical umbilical, a hydraulic umbilical or both.

Abstract: A selective stimulation system includes coiled tubing in which a distributed sensor array is disposed. The distributed sensor array is to measure hydrocarbon production parameters along the distributed sensor array in a wellbore of a formation. A selective fracturing apparatus is coupled to the coiled tubing. The selective fracturing apparatus is to fracture selected areas of the wellbore. A controller is coupled to the distributed sensor array and controls operation of the selective fracturing apparatus based on the measured hydrocarbon production parameters.

Abstract: A rapid deployment, subsea chemical injection skid assembly includes a non-buoyant skid lowered on a weight bearing line from a surface vessel. The skid carries a chemical injection pump, as well as at least one chemical tank in fluid communication with the chemical injection pump. The skid assembly may include a recirculation/mixing system to limit separation or solids drop out of chemicals arising from medium or long-term storage of chemicals in the chemical tank. The skid assembly may include a seawater filtration system to supply seawater for mixing with chemicals prior to injection. The skid assembly is operable by a separately tethered remotely operated vehicle.

Abstract: A subsea pump and power system having a base unit positioned on the seabed to which is detachably mounted a power module tethered to a surface power source via a power umbilical. The base unit includes process pumps for carrying out subsea pumping operations and is lowered by a heavy lift cable into position on the seabed adjacent a hydrocarbon production facility prior to lowering of the power module on a tether. The power module includes a power unit which may include an electrical motor, or a hydraulic pump or both, one or more of which are driven by the umbilical extending from the surface. The tether supports the weight of the power module as it is lowered to the base unit and includes an electrical umbilical, a hydraulic umbilical or both.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: A selective stimulation system includes coiled tubing in which a distributed sensor array is disposed. The distributed sensor array is to measure hydrocarbon production parameters along the distributed sensor array in a wellbore of a formation. A selective fracturing apparatus is coupled to the coiled tubing. The selective fracturing apparatus is to fracture selected areas of the wellbore. A controller is coupled to the distributed sensor array and controls operation of the selective fracturing apparatus based on the measured hydrocarbon production parameters.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: A spoolable swivel, methods, and systems for coupling a first and second length of coiled tubing. The spoolable swivel can include an inner tubular element and an outer tubular element. The inner tubular element and the outer tubular element can both have dimpled distal ends and races on their proximal ends, defining one or more annular voids for swivel bearings.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl -cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.

Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).